Memory-enhancing drug may improve exposure therapy for PTSD patients

November 3, 2011 in Psychology & Psychiatry

A memory-enhancing drug may improve the speed and effectiveness of prolonged exposure therapy for post-traumatic stress disorder (PTSD) patients, according to a new pilot study by psychologists at The University of Texas at Austin, the University of Washington and the University of Pennsylvania.

To lessen the time it takes for PTSD patients to recover, University of Texas at Austin psychology professors Michael Telch and Francisco Gonzalez-Lima, along with their team of researchers, are pairing prolonged exposure therapy with United States Pharmacopeia (USP) methylene blue.

In prolonged exposure therapy, patients repeatedly recount a fearful event. As the patients begin to look at the memory differently, the memory has less control over their lives.

The researchers believe the FDA-approved compound methylene blue, which significantly improved fear extinction in rats in an earlier study conducted in the Gonzalez-Lima Lab, will help strengthen memory that occurred during therapy sessions with PTSD patients. Normally, about two-thirds of PTSD patients treated with prolonged during ten 90-minute sessions no longer exhibit PTSD.

As part of the study, respondents take a placebo pill or a dose of USP methylene blue after a therapy session. The researchers theorize the drug will help patients recover faster and better in only six daily one-hour sessions.

Post-traumatic stress symptoms often emerge immediately after , such as combat experience, abuse, rape, robbery, accidents and . For most, these symptoms subside on their own soon after the trauma. However, about 30 percent of trauma victims go on to develop PTSD in which their trauma memories continue to haunt them and create significant distress and life impairment for months or years after the event.

Because prolonged, repeated recall of during behavior therapy stimulates new adaptive learning around the memories, the researchers predict that patients given a memory boost with USP methylene blue immediately after therapy sessions will make more lasting gains during therapy than those who do not take the medication.

Taken orally, the chemical properties of USP methylene blue affect regions of the brain, such as those stimulated after thinking about a memory.

“Methylene blue easily crosses the blood-brain barrier and accumulates inside activated brain cells,” Gonzalez-Lima says. “Once inside the neurons, the substance zooms in on mitochondria – the power house of the cell – to keep it active and enable the brain cells to keep processing the memory.”

Provided by University of Texas at Austin search and more info website

4 /5 (1 vote)  

Rank 4 /5 (1 vote)
Relevant PhysicsForums posts
  • Potential Breakthrough in Seizure Control
    created10 hours ago
  • Popping/Cracked sternum.
    created15 hours ago
  • Which Mental Illness Encompasses This Problem?
    created15 hours ago
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • More from Physics Forums - Medical Sciences

More news stories

More mental health care urged for kids who self-harm

(HealthDay) -- Doctors have long known that some kids suffering severe emotional turmoil find relief in physical pain -- cutting or burning or sticking themselves with pins to achieve a form of release.

Psychology & Psychiatry created May 25, 2012 | popularity not rated yet | comments 0

Questionable research practices surprisingly common

(Medical Xpress) -- Not all scientific misconduct is flat-out fraud. Much falls into the murkier realm of “questionable research practices.” A new study finds that in one field, psychology, these practices are surprisingly ...

Psychology & Psychiatry created May 25, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Feeling strong emotions makes peoples' brains 'tick together'

Experiencing strong emotions synchronises brain activity across individuals, research team at Aalto University and Turku PET Centre in Finland has revealed.

Psychology & Psychiatry created May 24, 2012 | popularity 5 / 5 (1) | comments 0

Formal recognition of PMDD will lift stigma for women

A decision to recognise premenstrual dysphoric disorder as a genuine psychiatric condition will finally provide “validation for this awful and poorly understood” syndrome and alleviate the stigma ...

Psychology & Psychiatry created May 24, 2012 | popularity 2 / 5 (1) | comments 1

Long-term meditation leads to different brain organization

(Medical Xpress) -- People who practice mindfulness meditation learn to accept their feelings, emotions, and states of mind without judging or resisting them. They simply live in the moment.

Psychology & Psychiatry created May 24, 2012 | popularity 5 / 5 (5) | comments 0 | with audio podcast


Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...